DONNA SMITH: Open Payments
NPI 1396744231 · CHARLOTTESVILLE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,281 in 63 payments from 17 companies in 2025. Trend: 2023 $879 · 2024 $1,112 · 2025 $1,281
Food & beverage: $1,281
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $270 |
| ABBVIE INC. | 11 | $237 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $187 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $116 |
| PFIZER INC. | 3 | $76 |
| Ipsen Biopharmaceuticals, Inc | 3 | $66 |
| GENZYME CORPORATION | 2 | $55 |
| QOL Medical, LLC | 2 | $53 |
| Madrigal Pharmaceuticals | 2 | $46 |
| Aimmune Therapeutics, Inc. | 1 | $34 |
Products named: TREMFYA, ENTYVIO, RINVOQ, XIFAXAN, IQIRVO, LINZESS, DUPIXENT, Sucraid.
Industry payments across VA — which companies pay providers there.
